Loading...
Observational study reveals drug resistance in acute myeloid leukemia cells due to protective bone marrow mesenchymal stem cells, suggesting new treatment strategies.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: